He added that Trump‘s case is “perhaps the most analyzed case report ever” but is “just low down on the evidence scale that we really need.”
He noted that clinical trials are the standard for whether it’s effective.
“The real evidence has to come about how good a drug is and what it will do on average has to come from these large clinical trials, these randomized clinical trials, which are the gold standard. And those are ongoing,” Schleifer said. “We’ve got some preliminary evidence that we’ve talked with the FDA, and we’re going for an emergency use authorization, because we think it’s appropriate at this time.”
Trump, who was hospitalized at Walter Reed National Military Medical Center after being diagnosed with coronavirus, was treated with the experimental antibody drug and touted it as a “cure.”
In an interview Sunday with Fox Business host Maria Bartiromo, Trump said he’s beaten Covid-19 and claimed immunity from the virus.
Asked by host Margaret Brennan as to whether Regeneron’s drug creates immunity, Schleifer said, “It does.”
“If you get it in our vial, if you will, that’s probably going to last you for months,” Schleifer said.